Consolidated Balance Sheets - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Current assets
Cash	$ 8,538,270	$ 2,629,670
Marketable equity securities, at fair value	1,892,837	2,063,236
Prepaid expenses	93,972	89,836
Note receivable - current	50,000
Total current assets	10,575,079	4,782,742
Note receivable		50,000
Investment in joint venture at fair value	410,000	410,000
Total assets	10,985,079	5,242,742
Current liabilities
Accounts payable	360,964	129,469
Accrued expenses	426,823	128,180
Accrued license fee - current portion	80,000	54,500
Total current liabilities	867,787	312,149
Accrued license fee - less current portion	235,000	285,000
Total liabilities	1,102,787	597,149
Commitments and contingencies
Stockholders’ equity
Preferred stock value
Common stock, $0.0001 par value, 75,000,000 shares authorized, 23,974,546 and 13,438,535 shares issued and outstanding at December 31, 2021 and 2020, respectively	2,398	1,343
Additional paid-in-capital	43,589,471	24,073,059
Accumulated deficit	(33,727,163)	(19,413,458)
Accumulated other comprehensive gain (loss)	17,586	(15,351)
Total stockholders’ equity	9,882,292	4,645,593
Total liabilities and stockholders’ equity	10,985,079	5,242,742
Series A Convertible Preferred Stock
Stockholders’ equity
Preferred stock value